2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 17.773 | 8.774 | 43.148 | 6.151 | 55.488 | - | 62.704 | 98.299 | 134.638 | - |
Total Income - EUR | 17.773 | 8.778 | 43.148 | 6.151 | 55.488 | - | 63.429 | 113.631 | 135.160 | - |
Total Expenses - EUR | 17.061 | 14.742 | 14.833 | 12.329 | 31.929 | - | 41.970 | 99.766 | 112.030 | - |
Gross Profit/Loss - EUR | 712 | -5.963 | 28.314 | -6.178 | 23.559 | - | 21.459 | 13.865 | 23.130 | - |
Net Profit/Loss - EUR | 179 | -6.227 | 27.883 | -6.239 | 23.045 | - | 21.063 | 12.733 | 21.858 | - |
Employees | 4 | 4 | 3 | 1 | 3 | - | 2 | 3 | 3 | - |
Check the financial reports for the company - Trivomed Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 66.495 | 63.867 | 61.019 | 57.716 | 55.218 | - | 98.116 | 73.342 | 66.762 | - |
Current Assets | 11.651 | 8.140 | 39.547 | 34.935 | 34.775 | - | 34.645 | 58.238 | 43.957 | - |
Inventories | 244 | 246 | 1.388 | 2.227 | 6.259 | - | 6.057 | 21.073 | 9.700 | - |
Receivables | 3.369 | 3.285 | 28.300 | 27.554 | 26.970 | - | 25.946 | 25.371 | 29.505 | - |
Cash | 8.039 | 4.609 | 9.859 | 5.155 | 1.546 | - | 2.642 | 11.795 | 4.751 | - |
Shareholders Funds | 16.395 | 10.305 | 38.082 | 31.216 | 23.111 | - | 42.197 | 53.994 | 8.302 | - |
Social Capital | 49 | 49 | 49 | 66 | 64 | - | 62 | 61 | 61 | - |
Debts | 61.751 | 61.702 | 62.484 | 61.435 | 66.881 | - | 90.565 | 77.587 | 102.417 | - |
Income in Advance | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | - |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8623 - 8623" | |||||||||
CAEN Financial Year |
8623
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Trivomed Srl